Back to Rare Disease
NCT06041906
NCT06041906
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with a congenital portosystemic shunt (CPSS), which is an abnormal blood vessel connection present from birth that bypasses the liver (confirm with trial site)
Who may not be able to join:
- Your shunt developed as a result of another condition (such as liver disease or high blood pressure in the liver's blood vessels) rather than being present from birth
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
By Invitation
Phase
Not Applicable
Sponsor
Prof. Valérie Mc Lin
Registry
clinicaltrials_gov
Start date
26 April 2018
Est. completion
26 October 2026
Where this trial is recruiting
🇦🇺 Australia
🇧🇪 Belgium
🇨🇦 Canada
🇫🇷 France
🇩🇪 Germany
🇭🇺 Hungary
🇮🇳 India
🇮🇱 Israel
🇮🇹 Italy
🇯🇵 Japan
🇳🇱 Netherlands
🇪🇸 Spain
🇨🇭 Switzerland
Turkey (Türkiye)
🇬🇧 United Kingdom
🇺🇸 United States
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Numbers of patients with spontaneous shunt closure; Number of patients developing one or more complications; Number of patients undergoing preemptive closure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.